Jazz Pharmaceuticals plc Net Income 2009–2025
Jazz Pharmaceuticals plc reported $-356.15M of net income for fiscal 2025. That was 163.6% lower than fiscal 2024. Compared with fiscal 2020, the change was -249.3%.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $-356.15M | -8.3% | -163.6% |
| FY 2024 | $560.12M | 13.8% | +35.0% |
| FY 2023 | $414.83M | 10.8% | +285.1% |
| FY 2022 | $-224.06M | -6.1% | +32.0% |
| FY 2021 | $-329.67M | -10.7% | -238.2% |
| FY 2020 | $238.62M | 10.1% | -54.4% |
| FY 2019 | $523.37M | 24.2% | +17.1% |
| FY 2018 | $447.10M | 23.6% | -8.4% |
| FY 2017 | $487.85M | 30.1% | +22.9% |
| FY 2016 | $396.83M | 26.7% | +20.4% |
| FY 2015 | $329.54M | 24.9% | +464.4% |
| FY 2014 | $58.39M | 5.0% | -73.0% |
| FY 2013 | $216.31M | 24.8% | -25.0% |
| FY 2012 | $288.59M | 49.2% | +130.9% |
| FY 2011 | $124.98M | 45.9% | +281.3% |
| FY 2010 | $32.78M | 18.9% | +579.5% |
| FY 2009 | $-6.84M | -5.3% | — |
Source: Jazz Pharmaceuticals plc SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open JAZZ 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Jazz Pharmaceuticals plc reported $-356.15M of net income for fiscal 2025. That was 163.6% lower than fiscal 2024. Compared with fiscal 2020, the change was -249.3%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Jazz Pharmaceuticals plc
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeJazz Pharmaceuticals plc — frequently asked questions
What is Jazz Pharmaceuticals plc's net income?
Jazz Pharmaceuticals plc (JAZZ) reported net income of $-356.15M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Jazz Pharmaceuticals plc's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.